DENNER ALEXANDER J 4

What Happened
Alexander J. Denner, a director of Ironwood Pharmaceuticals (IRWD), was granted a total of 67,546 restricted shares in two awards: 4,065 shares on 2026-06-15 and 63,481 shares on 2026-06-16. Both grants were recorded at $0.00 per share (total reported value $0) and are reported as award/acquisition transactions under the company’s non-employee director compensation policy. These are awards (compensation), not open-market purchases or sales.

Key Details

• Transaction dates and amounts: 2026-06-15 — 4,065 shares at $0.00; 2026-06-16 — 63,481 shares at $0.00.
• Transaction type: Award/Grant (Form 4 code "A") — restricted stock.
• Total shares granted: 67,546; total reported cash value: $0.
• Shares owned after transaction: Not specified in the filing.
• Footnotes: F1 — grants issued under the Second Amended and Restated Non‑employee Director Compensation Policy (effective Jan 1, 2024). F2 — restricted stock vests in full on the date immediately preceding the annual meeting of stockholders for the next calendar year.
• Filing timeliness: Form filed on 2026-06-17 covering transactions on 2026-06-15 and 06-16; filing appears to be within the required reporting window.

Context
These awards are standard non-employee director compensation (restricted stock that vests at a future date) and should be viewed as compensation, not an open-market investment signal. Vesting schedule is specified by the company policy (vesting occurs the day before next year’s annual meeting). No sale, exercise, or tax-withholding disposition was reported in this filing.